Alnylam Pharmaceuticals
ALNY
#651
Rank
$38.90 B
Marketcap
$291.37
Share price
-0.61%
Change (1 day)
-10.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company